SG biotech firm Nuevocor raises $24m in oversubscribed Series A round

SG biotech firm Nuevocor raises $24m in oversubscribed Series A round

Source: National Cancer Institute/Unsplash

Mars W. Mosqueda Jr.

18 June, 2021

BIFV EVX Ventures Nuevocor

Printed by Unregistered user on Sat, 05 Jul 2025 07:01:46 GMT

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief

Subscribe to Newsletter

You may also like

SG biotech startup Hummingbird Bioscience bags $125m Series C funding

US biotech firm NiKang Therapeutics raises $200m in Series C round

Read more from Singapore

Policy & Regulations

XL Ventures gets MAS nod to operate as VC fund manager

Beyond the Buyout: Dark side of Asia’s private credit boom